Archivé - Pour le public - Suspension volontaire des ventes de Zelnorm en raison d'effets indésirables cardiovasculaires ischémiques - Novartis Pharma Canada inc.
Émis le 2 avril 2007
Get notified of similar recallsEnter your email to receive alerts when new recalls are issued by the same agency.
Subscribed. You'll get an email when new recalls are issued.